Treatment of Giant Cell Arteritis (GCA) (2022), Régent A. | AcademicGPT, tlooto

Interestingly, mavrilimumab, ustekinumab and, to a lesser extent, abatacept have shown promising results in phase 2 randomised controlled trials, and the scientific rationale for each treatment and th (2022), Journal of Clinical Medicine, Régent A. | AcademicGPT, tlooto for Academic and Research